United Therapeutics | UTHR - Current Assets

Stock Price
568.58
Daily Change
-7.21 -1.25%
Monthly
-2.06%
Yearly
86.21%
Q2 Forecast
557.15

United Therapeutics reported $2.87B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Amarin USD 626.02M 23.87M Mar/2026
Ardelyx USD 381.87M 447K Mar/2026
Baxter International USD 6.85B 25M Mar/2026
Bayer EUR 35.3B 2.39B Mar/2026
BioCryst Pharmaceuticals USD 373.62M 30.72M Mar/2026
Biogen USD 9.19B 216.3M Mar/2026
BioMarin Pharmaceutical USD 4.61B 651.58M Mar/2026
Emergent BioSolutions USD 679.5M 41.3M Dec/2023
Esperion Therapeutics USD 459.46M 3.11M Mar/2026
Gilead Sciences USD 18.64B 1.25B Mar/2026
GlaxoSmithKline GBP 17.76B 251M Mar/2026
Halozyme Therapeutics USD 1B 177.83M Mar/2026
Insmed USD 1.61B 181.04M Mar/2026
Ionis Pharmaceuticals USD 2.94B 52M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Lexicon Pharmaceuticals USD 186.03M 84.14M Mar/2026
Moderna USD 5.77B 774M Mar/2026
Omeros USD 69.65M 26.53M Jun/2025
Pfizer USD 42.82B 76M Mar/2026
PTC Therapeutics USD 2.25B 19.94M Mar/2026
Regeneron Pharmaceuticals USD 18.21B 187.3M Mar/2026
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sarepta Therapeutics USD 2.31B 228.06M Mar/2026
Teva Pharmaceutical Industries USD 13.71B 236M Mar/2026
United Therapeutics USD 2.87B 830.5M Mar/2026
Vertex Pharmaceuticals USD 11.73B 529.3M Mar/2026